The global market for Genomics and Proteomics Reagents, Research Kits and Analytical Instruments was estimated at US$79.0 Billion in 2023 and is projected to reach US$156.5 Billion by 2030, growing at a CAGR of 10.3% from 2023 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions.
Global Genomics and Proteomics Reagents, Research Kits, and Analytical Instruments Market - Key Trends & Drivers Summarized
How Are Technological Advances Shaping Genomics and Proteomics?
The genomics and proteomics market has witnessed groundbreaking advancements in technology, with next-generation sequencing (NGS), CRISPR, and mass spectrometry transforming research capabilities. These technologies enable rapid, high-throughput analysis, allowing scientists to decode genetic and protein structures faster and with greater accuracy. Advancements in automation have also led to the development of highly sophisticated analytical instruments, minimizing human error and increasing reproducibility. Such technological progress is making genomics and proteomics research more accessible, supporting a variety of applications including personalized medicine, biomarker discovery, and drug development.Why Is Personalized Medicine Increasing Demand for Research Kits?
The rise of personalized medicine is driving demand for genomics and proteomics research kits, as these tools enable researchers to tailor treatments based on individual genetic and proteomic profiles. Kits that allow for the analysis of genetic variations and protein expression are crucial for identifying specific biomarkers associated with diseases. The growing focus on personalized treatment strategies in oncology, neurology, and cardiology has boosted the use of research kits and reagents, which are essential for conducting accurate and targeted studies. This trend supports healthcare`s shift toward customized treatment, aligning with patient-specific medical needs.How Are Academic and Pharmaceutical Investments Fueling Market Growth?
The genomics and proteomics field is receiving significant investments from both academic institutions and pharmaceutical companies eager to advance drug discovery and precision medicine. Government funding for academic research, particularly in areas like cancer genomics and infectious disease research, is supporting the development of new reagents and analytical instruments. Pharmaceutical companies are investing in proteomics to discover new drug targets and biomarkers, leading to increased demand for advanced research tools. These investments have positioned the genomics and proteomics market for growth as research accelerates and applications expand in healthcare.What Drives the Growth of the Genomics and Proteomics Market?
The growth in the genomics and proteomics reagents, research kits, and analytical instruments market is driven by technological advancements, the rise of personalized medicine, and increased investments in research. Innovations like NGS and CRISPR are enabling high-throughput and precise genetic analysis, which is essential for applications in drug discovery and biomarker research. Personalized medicine is also fueling demand for research tools, as patient-specific treatments require in-depth genetic and proteomic analysis. Academic and pharmaceutical investments are further bolstering market expansion, making genomics and proteomics essential components in advancing modern medicine.Key Insights:
- Market Growth: Understand the significant growth trajectory of the Biochips & Microarrays segment, which is expected to reach US$43.1 Billion by 2030 with a CAGR of a 9.0%. The Sample Preparation Kits segment is also set to grow at 11.4% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $21.1 Billion in 2023, and China, forecasted to grow at an impressive 13.7% CAGR to reach $34.6 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2023 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of major players in the Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments Market such as Advanced Instruments, Agilent Technologies, Inc., AMS Biotechnology (Europe) Ltd. (amsbio), BD Biosciences, Bioevopeak Co., Ltd. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 11 companies featured in this Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments market report include:
- Advanced Instruments
- Agilent Technologies, Inc.
- AMS Biotechnology (Europe) Ltd. (amsbio)
- BD Biosciences
- Bioevopeak Co., Ltd.
- Biognosys
- Bio-Rad Laboratories, Inc.
- Biosynth AG
- Breakthrough Genomics
- Bruker Corporation
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIII. MARKET ANALYSISCANADAITALYSPAINRUSSIAREST OF EUROPESOUTH KOREAREST OF ASIA-PACIFICARGENTINABRAZILMEXICOREST OF LATIN AMERICAIRANISRAELSAUDI ARABIAUNITED ARAB EMIRATESREST OF MIDDLE EASTIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
UNITED STATES
JAPAN
CHINA
EUROPE
FRANCE
GERMANY
UNITED KINGDOM
ASIA-PACIFIC
AUSTRALIA
INDIA
LATIN AMERICA
MIDDLE EAST
AFRICA
Companies Mentioned
Some of the 11 companies featured in this Global Genomics and Proteomics Reagents, Research Kits and Analytical Instruments market report include:- Advanced Instruments
- Agilent Technologies, Inc.
- AMS Biotechnology (Europe) Ltd. (amsbio)
- BD Biosciences
- Bioevopeak Co., Ltd.
- Biognosys
- Bio-Rad Laboratories, Inc.
- Biosynth AG
- Breakthrough Genomics
- Bruker Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 179 |
| Published | November 2024 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 79 Billion |
| Forecasted Market Value ( USD | $ 156.5 Billion |
| Compound Annual Growth Rate | 10.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
